|
|
||||
|
FDA expands disclosure
Email: Ted Agres - tedagres@lycos.com News from The Scientist 2004, 5(1):20040621-01
|
||||
|
|
||||
|
After what it termed a "comprehensive review" of more than 1800 previously approved requests from its employees to engage in "outside activities," the US Food and Drug Administration (FDA) has expanded the number of scientists and officials required to file confidential financial disclosure forms. The action comes as a congressional panel continues to scrutinize ethics and financial conflicts of interest rules at the FDA, the National Institutes of Health (NIH), and other federal agencies.
|
|
|||||||||
|
|||||||||
|